July 11, 2023
3 min watch
Save
VIDEO: Mouse trial in cabozantinib-resistant renal cell carcinoma shows promise
In this video, Farshid Sadeghi, MD, discussed data for a study examining cabozantinib-resistant kidney cancer at American Urological Association Annual Meeting.
Sadeghi, a clinical assistant professor at City of Hope Phoenix, highlighted a South Korean study that noted high rates of mutation in cabozantinib-resistant renal cell carcinoma and looked at ways to make them responsive to cabozantinib (Cabometyx, Exelixis) in mice.
“How this correlates to humans needs a lot more investigation, but as a physician who sees patients who have progression of disease on cabozantinib, this research is promising,” Sadeghi said.
Reference:
- Park JS, et al. PD24-08. Presented at: American Urological Association Annual Meeting; April 28-May 1, 2023; Chicago.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Sadeghi reports no relevant financial disclosures.
Read more about